A nomogram model for predicting the risk of checkpoint inhibitor‐related pneumonitis for patients with advanced non‐small‐cell lung cancer

Abstract Objective Immunotherapy extensively treats advanced non‐small‐cell lung cancer (NSCLC). Although immunotherapy is generally better tolerated than chemotherapy, it can cause multiple immune‐related adverse events (irAEs) involving multiple organs. Checkpoint inhibitor‐related pneumonitis (CI...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yao Zhang, Lincheng Zhang, Shuhui Cao, Yue Wang, Xuxinyi Ling, Yan Zhou, Hua Zhong
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2023-08-01
Edice:	Cancer Medicine
Témata:	checkpoint inhibitor‐related pneumonitis (CIP) immunotherapy nomogram non‐small‐cell lung cancer (NSCLC) predict
On-line přístup:	https://doi.org/10.1002/cam4.6244
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!